# NYPOZI

NDC: 69097-429
Generic name: filgrastim-txid
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20260211

FDA application: BLA761126

## Active ingredients

- FILGRASTIM: 480 ug/480ug

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-429"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-429
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=575d164d-45fa-4e3e-81e4-2652d96673d1